Clinical trials
Active, not recruiting Observational Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 8 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Centre, Singapore | 2 |
| Peking Union Medical College Hospital | 2 |
| Seoul National University Hospital | 2 |
| Superior University | 2 |
| Asan Medical Center | 1 |
| Cardiovascular and Interventional Radiological Society of Europe | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Eisai Inc. | 1 |
| Elephas | 1 |
| Exact Sciences Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 39 |
| Liver Neoplasms | 5 |
| Hepatitis B | 3 |
| Liver Cirrhosis | 3 |
| Cholangiocarcinoma | 2 |
| Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| COVID-19 | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.